Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Public Awareness and Attitude towards Counterfeit Medicines in Sudan: A cross-sectional study

Wala W. Wagiella, Shaza W. Shantier, Elrasheed A. Gadkariem
doi: https://doi.org/10.1101/2020.09.28.20201400
Wala W. Wagiella
1Department of Pharmacy Practice, Faculty of Pharmacy, University of Khartoum, Sudan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shaza W. Shantier
2Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Khartoum, Sudan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sshatier{at}yahoo.com
Elrasheed A. Gadkariem
2Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Khartoum, Sudan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Counterfeit medicines (CFMs) are a global problem with significant and well-documented consequences for global health and patient safety, including drug resistance and patient deaths. Reports of counterfeit pharmaceuticals in Africa indicate a wide variety of detrimental effects.

Objectives The aim of the present study was to assess the extent, awareness and attitude of public in Sudan towards CFMs.

Methods A cross-sectional study was conducted applying pretested and structured questionnaire. The awareness and attitude were assessed statistically and the association between those and different demographic characteristics was calculated using Fisher exact test and Spearman correlation.

Results A total of 386 participants have enrolled in the study. The majority of the respondents (58%) were found to be aware about the term CFMs with social media mentioned to be the main source. 73% of the respondents considered CFMs of worse quality suggesting getting the medicine from a trustworthy pharmacist in order to avoid buying CFMs. 56% reported their ability to distinguish CFMs from the side effects rather than the package and cost. Education was suggested by 82% of the respondents to have vital role in combating CFMs spread through workshops and campaigns. 68% of the participants were found to have a fair awareness about CFMs. Furthermore, 80% of them showed a good attitude toward CFMs

Conclusion Current literature includes gaps in knowledge and attitude towards CFMs. Therefore attention and concentrated efforts are required on the part of the government, drug manufacturers and health care providers’ especially pharmaceutical analysts to ensure that only drugs of acceptable quality reach the patient.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research is fully funded by the Ministry of Higher Education and Scientific Research, Sudan

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Research Committee, Faculty of Pharmacy, University of Khartoum

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All dataset supporting this article is available within the article and its supplementary files.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 30, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Public Awareness and Attitude towards Counterfeit Medicines in Sudan: A cross-sectional study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Public Awareness and Attitude towards Counterfeit Medicines in Sudan: A cross-sectional study
Wala W. Wagiella, Shaza W. Shantier, Elrasheed A. Gadkariem
medRxiv 2020.09.28.20201400; doi: https://doi.org/10.1101/2020.09.28.20201400
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Public Awareness and Attitude towards Counterfeit Medicines in Sudan: A cross-sectional study
Wala W. Wagiella, Shaza W. Shantier, Elrasheed A. Gadkariem
medRxiv 2020.09.28.20201400; doi: https://doi.org/10.1101/2020.09.28.20201400

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)